Leverage Cognate’s Unparalleled Cell-Based cGMP manufacturing expertise combined with a broad spectrum of targeted services for effective and optimized commercialization.
International experience providing full support through out all stages of commercial development. Cognate provides the most efficient translation from concept to market.
Cell Therapy Services
Access an array of technical and specialized manufacturing and development services backed by an unsurpassed track record and proven expertise with cell-based technologies.
Outstanding real-world experience in navigating the evolving international regulatory pathways coupled with global know-how in translating cGMP manufacturing between countries.
Notable Industry News
- Accurexa Announces Exclusive License Agreement With UC San Francisco Read more →
- NW Bio’s Cancer Vaccine Is The First Drug To Be Designated By UK Authorities As A “Promising Innovative Medicine” (PIM) Read more →
- Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market Read more →